A cost-effectiveness analysis of real-world treatment for elderly patients with multiple myeloma using a full disease model

Hedwig M. Blommestein; Silvia G. R. Verelst; Saskia de Groot; Peter C. Huijgens; Pieter Sonneveld; Carin A. Uyl-de Groot

doi:10.1111/ejh.12571

A cost-effectiveness analysis of real-world treatment for elderly patients with multiple myeloma using a full disease model

European Journal Of Haematology ◽

10.1111/ejh.12571 ◽

2015 ◽

Vol 96 (2) ◽

pp. 198-208 ◽

Cited By ~ 20

Author(s):

Hedwig M. Blommestein ◽

Silvia G. R. Verelst ◽

Saskia de Groot ◽

Peter C. Huijgens ◽

Pieter Sonneveld ◽

...

Keyword(s):

Multiple Myeloma ◽

Cost Effectiveness ◽

Elderly Patients ◽

Real World ◽

Disease Model ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis

Download Full-text

PCN163 SEQUENTIAL TREATMENT REGIMENS FOR ELDERLY PATIENTS WITH MULTIPLE MYELOMA: A COST-EFFECTIVENESS ANALYSIS INCLUDING EXPERIENCE FROM REAL-WORLD DATA

Value in Health ◽

10.1016/j.jval.2019.09.359 ◽

2019 ◽

Vol 22 ◽

pp. S467

Author(s):

U. Rochau ◽

D. Vukićević ◽

S. Angerer ◽

M. Schaffner ◽

V. Qerimi Rushaj ◽

...

Keyword(s):

Multiple Myeloma ◽

Cost Effectiveness ◽

Elderly Patients ◽

Real World ◽

Cost Effectiveness Analysis ◽

Sequential Treatment ◽

Real World Data ◽

World Data ◽

Treatment Regimens ◽

Effectiveness Analysis

Download Full-text

The application of the net-benefit approach in cost-effectiveness analysis of polypharmacy in the treatment of schizophrenia under real world treatment conditions

Psychiatrische Praxis ◽

10.1055/s-0031-1277799 ◽

2011 ◽

Vol 38 (S 01) ◽

Author(s):

R Kilian ◽

T Becker ◽

T Steinert ◽

G Längle

Keyword(s):

Cost Effectiveness ◽

Real World ◽

Cost Effectiveness Analysis ◽

Net Benefit ◽

Effectiveness Analysis ◽

Treatment Conditions

Download Full-text

Cost‐effectiveness analysis of treatment with varenicline for nicotine dependence compared with smoking cessation without pharmacotherapy in the real world

Pharmacoepidemiology and Drug Safety ◽

10.1002/pds.5359 ◽

2021 ◽

Author(s):

Takako Fujita ◽

Akira Babazono ◽

Peng Jiang ◽

Aziz Jamal ◽

Yunfei Li

Keyword(s):

Smoking Cessation ◽

Cost Effectiveness ◽

Nicotine Dependence ◽

Real World ◽

Cost Effectiveness Analysis ◽

The Real ◽

Effectiveness Analysis

Download Full-text

PCN111 Cost-Effectiveness Analysis of Ixazomib PLUS Lenalidomide-Dexamethasone Versus Daratumumab PLUS Lenalidomide-Dexamethasone in Multiple Myeloma Patients Received More THAN One PRIOR Treatment in China

Value in Health ◽

10.1016/j.jval.2020.08.248 ◽

2020 ◽

Vol 23 ◽

pp. S442

Author(s):

X. Zhao ◽

Y. Feng ◽

L. Zhu ◽

J. Liu

Keyword(s):

Multiple Myeloma ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Prior Treatment ◽

Effectiveness Analysis

Download Full-text

Cost-effectiveness analysis of low-molecular-weight heparin versus aspirin thromboprophylaxis in patients newly diagnosed with multiple myeloma

Thrombosis Research ◽

10.1016/j.thromres.2016.08.008 ◽

2016 ◽

Vol 145 ◽

pp. 119-125 ◽

Cited By ~ 6

Author(s):

Emilie Chalayer ◽

Aurélie Bourmaud ◽

Fabien Tinquaut ◽

Franck Chauvin ◽

Bernard Tardy

Keyword(s):

Molecular Weight ◽

Multiple Myeloma ◽

Cost Effectiveness ◽

Low Molecular Weight Heparin ◽

Cost Effectiveness Analysis ◽

Low Molecular Weight ◽

Newly Diagnosed ◽

Effectiveness Analysis

Download Full-text

PCN81 COST EFFECTIVENESS ANALYSIS OF BORTEZOMIB IN PREVIOUSLY UNTREATED MULTIPLE MYELOMA PATIENTS IN CANADA

Value in Health ◽

10.1016/s1098-3015(10)74332-1 ◽

2009 ◽

Vol 12 (7) ◽

pp. A272 ◽

Cited By ~ 1

Author(s):

K Yoong ◽

C Attard ◽

F Jivraj ◽

C Shustik ◽

D Reece

Keyword(s):

Multiple Myeloma ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis

Download Full-text

PCN41 Enhanced Cost-Effectiveness Analysis Using EHR Data for Real World Value

Value in Health ◽

10.1016/j.jval.2021.04.133 ◽

2021 ◽

Vol 24 ◽

pp. S26

Author(s):

A. Swaminathan ◽

C. Xu ◽

S. Zhang ◽

K. Du ◽

E. Siu ◽

...

Keyword(s):

Cost Effectiveness ◽

Real World ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis

Download Full-text

Cost-effectiveness analysis of dabigatran versus rivaroxaban for stroke prevention in patients with non-valvular atrial fibrillation using real-world evidence in elderly US Medicare beneficiaries

Current Medical Research and Opinion ◽

10.1080/03007995.2017.1375470 ◽

2017 ◽

Vol 34 (1) ◽

pp. 55-63 ◽

Cited By ~ 3

Author(s):

Siyang Peng ◽

Kristen A. Deger ◽

Anastasia Ustyugova ◽

Pranav Gandhi ◽

Nan Qiao ◽

...

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽

Real World ◽

Stroke Prevention ◽

Cost Effectiveness Analysis ◽

Medicare Beneficiaries ◽

Effectiveness Analysis ◽

Real World Evidence

Download Full-text

Real-World Data for the Evaluation of Transarterial Radioembolization versus Sorafenib in Hepatocellular Carcinoma: A Cost-Effectiveness Analysis

Value in Health ◽

10.1016/j.jval.2016.09.2397 ◽

2017 ◽

Vol 20 (3) ◽

pp. 336-344 ◽

Cited By ~ 13

Author(s):

Carla Rognoni ◽

Oriana Ciani ◽

Silvia Sommariva ◽

Rosanna Tarricone

Keyword(s):

Hepatocellular Carcinoma ◽

Cost Effectiveness ◽

Real World ◽

Cost Effectiveness Analysis ◽

Real World Data ◽

World Data ◽

Transarterial Radioembolization ◽

Effectiveness Analysis

Download Full-text

Implementation of a Procalcitonin-Guided Antimicrobial Use in Intensive Care Unit Patients with Sepsis: A Cost-Effectiveness Analysis Utilizing Real-World Experiences

Open Forum Infectious Diseases ◽

10.1093/ofid/ofw172.1408 ◽

2016 ◽

Vol 3 (suppl_1) ◽

Author(s):

Curtis Collins ◽

Kara Brockhaus ◽

Taeyong Sim ◽

Anupam Suneja ◽

Anurag Malani

Keyword(s):

Intensive Care Unit ◽

Intensive Care ◽

Cost Effectiveness ◽

Real World ◽

Cost Effectiveness Analysis ◽

Antimicrobial Use ◽

Effectiveness Analysis

Download Full-text